Cambridge Healthtech Institute's Inaugural

Immuno-Oncology Investing & Partnering Forum

( 投资与合作癌症免疫领域的相关论坛 )

Facilitating Partnering, Funding & Investment to Advance Immuno-Oncology Drugs


Cambridge Healthtech Institute is pleased to announce the Inaugural Immuno-Oncology Investing & Partnering Forum to run as part of the Immuno-Oncology Summit in Boston on August 30, 2018. This timely and focused event brings together early- and late-stage investors with fundraising CEOs and research entrepreneurs to encourage partnering and investment, and to ultimately accelerate immune-oncology therapies to market. This Forum will provide ample opportunity for both investors and CEOs to interact through pre-scheduled 1-1 meetings, as well as interactive panels presented by pharma business development and the VC/investment community. Both late-stage and emerging tech companies will present on the agenda.

Cover will include, but is not limited to:

  • Pharmaceuticals
  • Biotechnology
  • Venture Capital Firms
  • Angel Investors
  • Young Companies
  • Emerging Companies

* 活动内容有可能不事先告知作更动及调整。

Choose your language